NORDIC BIOTECH HOLDING ApS: Financial statements 2023
CVR: 26409683
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
NORDIC BIOTECH HOLDING ApS (CVR 26409683) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -626,579 and a net result of DKK -514,945 compared with DKK 95,776 the year before. Equity in the 2023 report amounted to DKK 578,106. The solvency ratio was 56.4%.
- Gross Profit
- DKK -626,579
- Profit/Loss
- DKK -514,945
- Equity
- DKK 578,106
- Total Assets
- DKK 1,024,988
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -627K | -515K | 578K | - |
| 2022 | - | 114K | 96K | 854K | 1 |
| 2021 | - | 325K | 305K | 758K | 1 |
| 2020 | - | 442K | 325K | -462K | 1 |
| 2019 | - | -697K | -688K | -788K | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
NORDIC BIOTECH HOLDING ApS has published its annual report for 2022. Gross profit came to DKK 113,606, and the net result was DKK 95,776.
About NORDIC BIOTECH HOLDING ApS
NORDIC BIOTECH HOLDING ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2001. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named SN BIOTECH HOLDING ApS. The management consists of Torsten Bjørn. The company is owned by FINANSMANAGEMENT ApS. The company has 1 employee (2012). In 2025, the company reported a gross profit of DKK -39,555 and a net result of DKK -7,860 compared with DKK -39,278 the year before. Equity in the 2025 report amounted to DKK 139,260.
